Recombinant Human GNPTG Protein: Function & Research Use

Recombinant Human GNPTG Protein is a recombinantly produced form of the gamma subunit of UDP-GlcNAc:lysosomal-enzyme GlcNAc-1-phosphotransferase, an enzyme complex essential for generating mannose-6-phosphate recognition markers that direct hydrolases to the lysosome.

Gene Name

GNPTG

Protein Full Name

GlcNAc-1-phosphotransferase gamma subunit (N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase)

Biological Function

Cleaves GlcNAc-1-phosphodiester intermediates to expose mannose-6-phosphate residues on lysosomal hydrolases, enabling receptor-mediated lysosomal targeting

Associated Disease

Mucolipidosis type III gamma (ML III gamma); lysosomal storage disorder caused by GNPTG mutations

Product SKU

rp365448

Species

Human (Homo sapiens)

Protein Type

Recombinant protein, subunit of a heterohexameric enzyme complex

Background: The GNPTG Gene and Its Encoded Protein

The GNPTG gene encodes the gamma (γ) subunit of UDP-GlcNAc:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase, commonly abbreviated as GlcNAc-1-phosphotransferase. This enzyme is a heterohexameric complex composed of two alpha (α), two beta (β), and two gamma (γ) subunits. The α and β subunits, encoded by GNPTAB, carry the catalytic phosphotransferase activity, while the γ subunit encoded by GNPTG plays an essential regulatory and recognition role.

The GNPTG protein functions as an uncovering enzyme that cleaves GlcNAc-1-phosphodiester intermediates on newly synthesized lysosomal hydrolases. This cleavage exposes mannose-6-phosphate (M6P) residues, which serve as molecular recognition signals for M6P receptors located in the trans-Golgi network and on the cell surface. Through this mechanism, lysosomal hydrolases are correctly packaged and transported to the lysosome.

Disruption of GNPTG function impairs the efficient generation of M6P tags, leading to the missorting of lysosomal enzymes and their secretion into the extracellular space rather than delivery to lysosomes. This underlies the pathology of Mucolipidosis type III gamma (ML III gamma), a rare autosomal recessive lysosomal storage disorder.

Biochemical Properties of Recombinant Human GNPTG Protein

Recombinant Human GNPTG Protein (SKU: rp365448) is produced using recombinant expression systems to yield a highly pure preparation of the human GNPTG subunit suitable for in vitro research. Recombinant production allows researchers to study the GNPTG subunit in isolation, enabling mechanistic dissection of its contribution to the overall GlcNAc-1-phosphotransferase complex.

Key biochemical considerations for working with recombinant GNPTG include its role as a peripheral subunit that enhances substrate recognition by the phosphotransferase complex. The γ subunit has been reported to interact with specific structural domains on lysosomal hydrolase substrates, contributing to the selectivity of M6P tagging. Researchers should note that the isolated γ subunit does not independently possess phosphotransferase catalytic activity; full enzymatic activity requires assembly with the α/β subunits.

When handling the recombinant protein, standard precautions for recombinant proteins apply: avoid repeated freeze-thaw cycles, store aliquots at the recommended temperature, and reconstitute lyophilized material according to the supplier's protocol. Specific formulation, purity grade, and storage conditions for SKU rp365448 should be confirmed in the product datasheet provided by Aladdin Scientific.

Research Applications

Recombinant Human GNPTG Protein supports a broad range of research applications in cell biology, biochemistry, and disease modeling:

• Enzyme complex reconstitution: The recombinant γ subunit can be combined with recombinant α/β subunits to reconstitute GlcNAc-1-phosphotransferase activity in vitro, providing a defined system for mechanistic and kinetic studies.
• Protein-protein interaction studies: GNPTG can be used in pull-down assays, co-immunoprecipitation experiments, or surface plasmon resonance to map its interactions with the α/β catalytic subunits and with lysosomal hydrolase substrates.
• Structural biology: Purified recombinant GNPTG protein serves as material for crystallography or cryo-EM studies aimed at resolving the three-dimensional architecture of the phosphotransferase complex or the isolated γ subunit.
• Mucolipidosis disease modeling: Researchers studying ML II or ML III can use the recombinant protein as a reference standard in activity assays or to generate antibodies for detecting endogenous GNPTG in patient-derived cell lines.
• Antibody validation and immunoassay development: Recombinant GNPTG serves as an antigen for raising polyclonal or monoclonal antibodies and as a positive control in Western blot, ELISA, or immunohistochemistry workflows.

Relevance to Lysosomal Storage Disorders

Lysosomal storage disorders (LSDs) are a group of inherited metabolic diseases characterized by the dysfunction of lysosomal enzymes or membrane proteins, leading to the abnormal accumulation of substrates within lysosomes. GNPTG mutations specifically cause Mucolipidosis type III gamma (ML III gamma), also known as pseudo-Hurler polydystrophy gamma variant.

In ML III gamma, reduced GlcNAc-1-phosphotransferase activity leads to deficient M6P tagging of multiple lysosomal hydrolases. These enzymes are consequently missorted and secreted extracellularly, while the lysosome is deprived of functional degradative capacity. Clinically, ML III gamma manifests with progressive skeletal deformities, joint stiffness, mild intellectual disability in some patients, and corneal clouding, with onset typically in early childhood.

Recombinant Human GNPTG Protein provides a valuable tool for researchers developing enzyme replacement strategies, studying the molecular basis of M6P pathway defects, or screening small-molecule correctors that restore GNPTG function or complex assembly. It is also useful in translational research aimed at understanding genotype-phenotype correlations in ML III gamma patients.

Frequently asked questions

What is the function of the GNPTG protein in cells?

GNPTG encodes the gamma subunit of GlcNAc-1-phosphotransferase, an enzyme complex in the Golgi apparatus. The γ subunit acts as an uncovering enzyme that cleaves GlcNAc-1-phosphodiester intermediates on nascent lysosomal hydrolases, exposing mannose-6-phosphate (M6P) recognition markers required for receptor-mediated lysosomal targeting. Without proper GNPTG activity, lysosomal enzymes are missorted and secreted rather than delivered to the lysosome.

Can Recombinant Human GNPTG Protein be used to reconstitute phosphotransferase enzyme activity in vitro?

The isolated recombinant GNPTG (γ) subunit does not independently possess GlcNAc-1-phosphotransferase catalytic activity, as this activity resides in the α/β subunits encoded by GNPTAB. However, when combined with recombinant α/β subunits under appropriate reconstitution conditions, the γ subunit contributes to complex assembly and enhances substrate recognition, enabling functional in vitro studies of the full heterohexameric complex.

What disease is associated with GNPTG mutations?

Mutations in GNPTG cause Mucolipidosis type III gamma (ML III gamma), a rare autosomal recessive lysosomal storage disorder. It is characterized by impaired M6P tagging of lysosomal enzymes, resulting in their extracellular secretion and progressive substrate accumulation in lysosomes. Clinical features include skeletal deformities, joint stiffness, and, in some patients, mild intellectual disability and corneal clouding.

How should Recombinant Human GNPTG Protein (rp365448) be stored?

General best practice for recombinant proteins is to store aliquots at -80°C to avoid repeated freeze-thaw cycles, which can reduce activity and promote aggregation. Lyophilized preparations should be reconstituted according to the manufacturer's instructions. Please refer to the official product datasheet for SKU rp365448 from Aladdin Scientific for the precise formulation, recommended storage temperature, and shelf-life information.

References

1. Raas-Rothschild A, Cormier-Daire V, Bao M, et al. Molecular basis of variant pseudo-Hurler polydystrophy (mucolipidosis IIIC). J Clin Invest. 2000;105(5):673-681. doi:10.1172/JCI8826
2. Kornfeld S. Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest. 1986;77(1):1-6. doi:10.1172/JCI112262
3. Tiede S, Storch S, Lubke T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11(10):1109-1112. doi:10.1038/nm1305
4. UniProt Consortium. GNPTG_HUMAN (Q9UKU9). UniProtKB. Accessed 2024.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.